Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:LCI

Lannett (LCI) Stock Price, News & Analysis

Lannett logo

About Lannett Stock (NYSE:LCI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.65
$2.51
52-Week Range
N/A
Volume
280,600 shs
Average Volume
92,067 shs
Market Capitalization
$7.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Receive LCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

LCI Stock News Headlines

Lucky Core Industries Ltd.
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
LANNETT SHARES UPDATE
Why Lannett (LCI) Stock Is Down Today
See More Headlines

LCI Stock Analysis - Frequently Asked Questions

Lannett Company, Inc. (NYSE:LCI) issued its earnings results on Wednesday, November, 3rd. The company reported ($1.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.00) by $0.08. The business earned $101.53 million during the quarter, compared to analysts' expectations of $98.62 million.
Read the conference call transcript
.

Shares of Lannett reverse split before market open on Tuesday, February 7th 2023. The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lannett investors own include Bristol-Myers Squibb (BMY), Akorn (AKRX), Micron Technology (MU), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), AT&T (T) and Bank of America (BAC).

Company Calendar

Last Earnings
11/03/2021
Today
4/27/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:LCI
Employees
810
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-231,620,000.00
Pretax Margin
-62.67%

Debt

Sales & Book Value

Annual Sales
$340.58 million
Price / Cash Flow
N/A
Book Value
($23.34) per share
Price / Book
N/A

Miscellaneous

Free Float
9,354,000
Market Cap
$7.38 million
Optionable
Optionable
Beta
0.95

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:LCI) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners